Annual CFO
-$117.49 M
-$68.46 M-139.63%
31 December 2023
Summary:
Tarsus Pharmaceuticals annual cash flow from operations is currently -$117.49 million, with the most recent change of -$68.46 million (-139.63%) on 31 December 2023. During the last 3 years, it has fallen by -$96.36 million (-455.84%). TARS annual CFO is now -3234.82% below its all-time high of $3.75 million, reached on 31 December 2021.TARS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$8.65 M
+$5.75 M+39.93%
30 September 2024
Summary:
Tarsus Pharmaceuticals quarterly cash flow from operations is currently -$8.65 million, with the most recent change of +$5.75 million (+39.93%) on 30 September 2024. Over the past year, it has increased by +$23.71 million (+73.26%). TARS quarterly CFO is now -142.10% below its all-time high of $20.55 million, reached on 30 June 2021.TARS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$100.18 M
+$23.71 M+19.14%
30 September 2024
Summary:
Tarsus Pharmaceuticals TTM cash flow from operations is currently -$100.18 million, with the most recent change of +$23.71 million (+19.14%) on 30 September 2024. Over the past year, it has dropped by -$11.15 million (-12.52%). TARS TTM CFO is now -1810.72% below its all-time high of $5.86 million, reached on 30 September 2021.TARS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARS Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -139.6% | +73.3% | -12.5% |
| 3 y3 years | -455.8% | -221.7% | -1810.7% |
| 5 y5 years | -9831.8% | - | - |
TARS Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3234.8% | at low | -221.7% | +78.0% | -1810.7% | +24.9% |
| 5 y | 5 years | -3234.8% | at low | -142.1% | +78.0% | -1810.7% | +24.9% |
| alltime | all time | -3234.8% | at low | -142.1% | +78.0% | -1810.7% | +24.9% |
Tarsus Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$8.65 M(-39.9%) | -$100.18 M(-19.1%) |
| June 2024 | - | -$14.40 M(-61.9%) | -$123.89 M(-7.1%) |
| Mar 2024 | - | -$37.79 M(-3.9%) | -$133.31 M(+13.5%) |
| Dec 2023 | -$117.49 M(+139.6%) | -$39.34 M(+21.5%) | -$117.49 M(+32.0%) |
| Sept 2023 | - | -$32.36 M(+35.8%) | -$89.03 M(+18.3%) |
| June 2023 | - | -$23.83 M(+8.4%) | -$75.28 M(+35.1%) |
| Mar 2023 | - | -$21.97 M(+102.0%) | -$55.71 M(+13.6%) |
| Dec 2022 | -$49.03 M | -$10.87 M(-41.6%) | -$49.03 M(-2.5%) |
| Sept 2022 | - | -$18.61 M(+337.0%) | -$50.28 M(+104.8%) |
| June 2022 | - | -$4.26 M(-72.1%) | -$24.55 M(-9691.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$15.29 M(+26.1%) | $256.00 K(-93.2%) |
| Dec 2021 | $3.75 M(-117.7%) | -$12.12 M(-270.4%) | $3.75 M(-36.0%) |
| Sept 2021 | - | $7.11 M(-65.4%) | $5.86 M(-174.8%) |
| June 2021 | - | $20.55 M(-274.2%) | -$7.83 M(-74.7%) |
| Mar 2021 | - | -$11.79 M(+17.8%) | -$30.94 M(+46.4%) |
| Dec 2020 | -$21.14 M(+475.5%) | -$10.01 M(+52.4%) | -$21.14 M(+90.0%) |
| Sept 2020 | - | -$6.57 M(+157.0%) | -$11.13 M(+144.3%) |
| June 2020 | - | -$2.56 M(+28.1%) | -$4.55 M(+128.1%) |
| Mar 2020 | - | -$2.00 M | -$2.00 M |
| Dec 2019 | -$3.67 M(+210.5%) | - | - |
| Dec 2018 | -$1.18 M | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual CFO year-on-year change?
- What is Tarsus Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly CFO year-on-year change?
- What is Tarsus Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM CFO year-on-year change?
What is Tarsus Pharmaceuticals annual cash flow from operations?
The current annual CFO of TARS is -$117.49 M
What is the all time high annual CFO for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual cash flow from operations is $3.75 M
What is Tarsus Pharmaceuticals annual CFO year-on-year change?
Over the past year, TARS annual cash flow from operations has changed by -$68.46 M (-139.63%)
What is Tarsus Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of TARS is -$8.65 M
What is the all time high quarterly CFO for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly cash flow from operations is $20.55 M
What is Tarsus Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, TARS quarterly cash flow from operations has changed by +$23.71 M (+73.26%)
What is Tarsus Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of TARS is -$100.18 M
What is the all time high TTM CFO for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM cash flow from operations is $5.86 M
What is Tarsus Pharmaceuticals TTM CFO year-on-year change?
Over the past year, TARS TTM cash flow from operations has changed by -$11.15 M (-12.52%)